NewYork-Presbyterian Hospital

Advanced Search


Cancer Prevention Newsletter

Celiac Disease and Risk of Cancer

Diarrhea is not a topic most of us like to think about too much. In most instances, it arises from acute infections or minor indiscretions in our eating. However, in the United States, there are some children and adults who develop significant diarrhea as a result of malabsorption that occurs when they consume foods that contain gluten, a protein found in certain grains including wheat, barley, and rye. This condition is called celiac disease. 

 

About Celiac Disease

Celiac disease (also known as gluten-sensitive enteropathy) is an autoimmune disorder affecting the small bowel. It can be diagnosed on biopsy and on the basis of certain blood tests. Patients who present with diarrhea are thought to be just the tip of the celiac iceberg; in fact, the majority may not have severe diarrhea. Anemia, osteoporosis, and symptoms suggestive of irritable bowel syndrome may be the only manifestations of the disease. Celiac disease is a common disorder in Great Britain and certain parts of Europe, but its exact prevalence in the United States is uncertain - estimates place the number of individuals with celiac disease between 500,000 and several million. In many cases, avoidance of gluten is sufficient for controlling the symptoms and the disease. Clearly, however, practitioners often overlook this patient population. 

Research and Awareness

Peter Green, M.D., Clinical Professor of Medicine and Attending Physician in the Division of Digestive and Liver Disorders at New York-Presbyterian Hospital, has taken a special interest in celiac disease. Over the past 20 years, Dr. Green has established a Center for the diagnosis, treatment, and study of people with celiac disease, and has collected data on overt 400 patients, including follow-up on gluten-free diets. 

A major interest has been the risk of malignancy in the people with celiac disease. While cancers of the large bowel are common in the United States and Western Europe, adenocarcinoma of the small bowel is a very rare disorder, occurring at a rate of 1/50th that of large bowel cancer. Yet, studies in the United Kingdom have recently demonstrated that the risk for small bowel adenocarcinoma in people with celiac disease is 50 to 100 times the normal rate - which makes this condition virtually as common in people with celiac disease as the risk of colorectal cancer in the general population. Dr. Green suspects that the condition may have different characteristics, particularly based on the lower frequency of celiac disease in the United States. However, Dr. Green and his colleagues have recently published data in which the risk of small bowel adenocarcinoma in patients with celiac disease within his Center was approximately 70-fold the average risk of small bowel adenocarcinoma. 

Dr. Green has also conducted further studies in which the risk of non-Hodgkin’s lymphoma was shown to be dramatically elevated in people with celiac disease. Furthermore, many of these lymphomas occurred within the small bowel itself. Other findings confirmed earlier reports that esophageal carcinoma was also elevated in these patients, although the reasons are unknown. More importantly, while preliminary, Dr. Green’s studies suggest that adherence to a gluten-free diet can rapidly diminish the risk for these cancers.
 

For entry to Dr. Green’s Center or for further information, please call 212-305-5590.